Avyakta Kallam

1.5k total citations
52 papers, 249 citations indexed

About

Avyakta Kallam is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Avyakta Kallam has authored 52 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 26 papers in Pathology and Forensic Medicine and 14 papers in Genetics. Recurrent topics in Avyakta Kallam's work include Lymphoma Diagnosis and Treatment (26 papers), CAR-T cell therapy research (17 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Avyakta Kallam is often cited by papers focused on Lymphoma Diagnosis and Treatment (26 papers), CAR-T cell therapy research (17 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Avyakta Kallam collaborates with scholars based in United States, Switzerland and India. Avyakta Kallam's co-authors include Julie M. Vose, Lynette M. Smith, R. Gregory Bociek, Adams K. Appiah, Vinicius Ernani, Apar Kishor Ganti, Peter T. Silberstein, Valerie Shostrom, Jamés O. Armitage and Ariel Modrykamien and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Molecular Sciences.

In The Last Decade

Avyakta Kallam

42 papers receiving 248 citations

Peers

Avyakta Kallam
Árpád Szomor Hungary
K. Govind Babu India
L K Rajeev India
Yasunobu Sekiguchi Japan
Hanno M. Witte Germany
Heather Lin United States
Kateřina Steinerová Czechia
Lynny Yung United Kingdom
Wanda Knopińska‐Posłuszny Poland
Francesco Pietrogrande Italy
Árpád Szomor Hungary
Avyakta Kallam
Citations per year, relative to Avyakta Kallam Avyakta Kallam (= 1×) peers Árpád Szomor

Countries citing papers authored by Avyakta Kallam

Since Specialization
Citations

This map shows the geographic impact of Avyakta Kallam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avyakta Kallam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avyakta Kallam more than expected).

Fields of papers citing papers by Avyakta Kallam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avyakta Kallam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avyakta Kallam. The network helps show where Avyakta Kallam may publish in the future.

Co-authorship network of co-authors of Avyakta Kallam

This figure shows the co-authorship network connecting the top 25 collaborators of Avyakta Kallam. A scholar is included among the top collaborators of Avyakta Kallam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avyakta Kallam. Avyakta Kallam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shouse, Geoffrey, Lu Chen, D. Lynne Smith, et al.. (2025). Copanlisib in combination with venetoclax in patients with relapsed/refractory mantle cell lymphoma. Leukemia & lymphoma. 66(14). 2790–2793.
3.
Xiao, Annie, Lu Chen, Matthew Mei, et al.. (2025). Real-world infectious complications of CD3/CD20 bispecific antibodies in relapsed/refractory non-Hodgkin lymphoma. Leukemia & lymphoma. 66(12). 2260–2268.
4.
5.
Kallam, Avyakta. (2023). Current Treatments in Mantle Cell Lymphoma. PubMed. 37(3708). 326–333.
6.
Zain, Jasmine & Avyakta Kallam. (2023). Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicability. Frontiers in Oncology. 13. 1150715–1150715. 3 indexed citations
7.
Schmit-Pokorny, Kim, Deborah A. Swanson, Valerie Shostrom, et al.. (2021). Assessment of Time to CAR-T Cell Therapy and Patients’ Outcomes in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Based on Insurance Status (Public Versus Private) and Distance Traveled to Treatment Center. Transplantation and Cellular Therapy. 27(3). S302–S303. 1 indexed citations
8.
Bociek, R. Gregory, Michelle A. Fanale, Swaminathan P. Iyer, et al.. (2021). Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma. Annals of Hematology. 101(2). 335–340. 2 indexed citations
9.
Wang, Michael, Matthew Mei, Paul M. Barr, et al.. (2021). Phase 1 Dose Escalation and Cohort Expansion Study of the Anti-ROR1 Antibody-Drug Conjugate Zilovertamab Vedotin (MK-2140) for the Treatment of Non-Hodgkin Lymphoma. Blood. 138(Supplement 1). 528–528. 7 indexed citations
10.
Ellithi, Moataz, et al.. (2021). Outcomes of Richter’s transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database. Annals of Hematology. 100(10). 2513–2519. 26 indexed citations
11.
Padala, Sandeep & Avyakta Kallam. (2020). Cancer, Clear Cell Renal Carcinoma. StatPearls. 2 indexed citations
12.
Abughanimeh, Omar, et al.. (2020). Fenbendazole as a Treatment for Diffuse Large B-CellLymphoma. 1 indexed citations
13.
Kallam, Avyakta & Jamés O. Armitage. (2020). Contemporary strategies to improve outcomes for peripheral T-cell lymphoma patients following the failure of first-line therapy. Expert Review of Hematology. 13(7). 745–753.
14.
Kallam, Avyakta, et al.. (2020). Central Nervous System Post-transplant Lymphoproliferative Disorder: Response to Ibrutinib. Clinical Lymphoma Myeloma & Leukemia. 20(11). e930–e933. 2 indexed citations
15.
Kallam, Avyakta, Jayanth Adusumalli, & Jamés O. Armitage. (2020). Surveillance in Patients With Diffuse Large B Cell Lymphoma. Mayo Clinic Proceedings. 95(1). 157–163. 5 indexed citations
16.
Kallam, Avyakta & Julie M. Vose. (2019). Recent Advances in CAR-T Cell Therapy for Non-Hodgkin Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 19(12). 751–757. 19 indexed citations
17.
Appiah, Adams K., et al.. (2019). HPV Status and Survival in Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck. Anticancer Research. 39(4). 1907–1914. 34 indexed citations
18.
19.
Kommalapati, Anuhya, et al.. (2018). Upper Limb Phlegmasia Cerulea Dolens Secondary to Heparin-induced Thrombocytopenia Leading to Gangrene. Cureus. 10(6). e2853–e2853. 5 indexed citations
20.
Kallam, Avyakta, et al.. (2014). Proton pump induced thrombocytopenia: A case report and review of literature. Platelets. 26(6). 598–601. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Árpád Szomor Breakdown of academic impact, for papers by K. Govind Babu Breakdown of academic impact, for papers by L K Rajeev Breakdown of academic impact, for papers by Yasunobu Sekiguchi Breakdown of academic impact, for papers by Hanno M. Witte Breakdown of academic impact, for papers by Heather Lin Breakdown of academic impact, for papers by Kateřina Steinerová Breakdown of academic impact, for papers by Lynny Yung Breakdown of academic impact, for papers by Wanda Knopińska‐Posłuszny Breakdown of academic impact, for papers by Francesco Pietrogrande
Rankless by CCL
2026